Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.

The complement activating venom component Cobra Venom Factor (CVF), a functional and structural homologue of the human complement component C3, forms a stable CVF-dependent C3 convertase complex, which, in contrast to C3-dependent convertase effects continuous activation of the complement and, thereby, decomplementation. In order to elucidate the mechanism underlying the enhanced activity of CVF compared to human C3, we generated two CVF/C3 chimeras and established different affinity-based assay systems for functional analysis of these constructs. To allow for convenient expression and subsequent functional characterisation, the CVF/C3 chimeras as well as CVF and C3 were transiently expressed in mammalian cells. Problems due to the low concentration of the recombinant proteins in the supernatants of transient expressions were circumvented by fusion to peptide tags enabling their efficient immobilisation onto suitable surfaces and subsequent characterisation. In an alternative approach monoclonal antibody fragments generated from a semisynthetic phage display scFv library were employed for concentrating the recombinant proteins by immunoprecipitation. Utilising both approaches all transiently expressed proteins could be characterised for their complement consumption activity. The data obtained with the CVF/C3 chimeras demonstrate that the increased stability of the CVFBb complex is independent of the domains in CVF corresponding to binding sites of factor B and H and the cleavage sites of factor I in the human C3 molecule.

[1]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[2]  A. Plückthun,et al.  Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.

[3]  C. Alper,et al.  Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement). , 1976, Science.

[4]  H R Hoogenboom,et al.  Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. , 1991, Nucleic acids research.

[5]  O. Götze,et al.  Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway , 1976, The Journal of experimental medicine.

[6]  H. Müller-Eberhard,et al.  Cobra venom factor: improved method for purification and biochemical characterization. , 1984, Journal of immunological methods.

[7]  R. Harrison,et al.  Structural characterization of factor I mediated cleavage of the third component of complement. , 1982, Biochemistry.

[8]  M. Kock,et al.  Structure and function of cobra venom factor, the complement-activating protein in cobra venom. , 1996, Advances in experimental medicine and biology.

[9]  C. Cochrane,et al.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. , 1969, Journal of immunology.

[10]  C. Silverman,et al.  Heavy Chain Dimers as Well as Complete Antibodies Are Efficiently Formed and Secreted from Drosophila via a BiP-mediated Pathway (*) , 1995, The Journal of Biological Chemistry.

[11]  B. Weintraub,et al.  Expression of Biologically Active Human Thyrotropin (hTSH) in a Baculovirus System: Effect of Insect Cell Glycosylation on hTSH Activity in Vitro and in Vivo1. , 1997, Endocrinology.

[12]  R. Bruccoleri,et al.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Lambris,et al.  A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides. , 1988, The Journal of biological chemistry.

[14]  H. Müller-Eberhard,et al.  The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. , 1982, The Journal of biological chemistry.

[15]  H. Müller-Eberhard,et al.  Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. , 1971, Journal of immunology.

[16]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[17]  G. Winter,et al.  Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.

[18]  P. T. Jones,et al.  Isolation of high affinity human antibodies directly from large synthetic repertoires. , 1994, The EMBO journal.

[19]  P. Lachmann,et al.  The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. , 1975, Clinical and experimental immunology.

[20]  R. Possee Cell-surface expression of influenza virus haemagglutinin in insect cells using a baculovirus vector. , 1986, Virus research.

[21]  E. Petrella,et al.  Immunoreactivity and function of oligosaccharides in cobra venom factor. , 1994, Journal of immunology.

[22]  R. Frank,et al.  Molecular interaction between the Strep-tag affinity peptide and its cognate target, streptavidin. , 1996, Journal of molecular biology.

[23]  M. Paulsson,et al.  Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. , 1999, Clinical chemistry.

[24]  R. Bredehorst,et al.  Molecular cloning and derived primary structure of cobra venom factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Caporale,et al.  A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. , 1988, The Journal of biological chemistry.

[26]  Y. Okada,et al.  TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.

[27]  John D Lambris,et al.  Overexpression, purification, and characterization of third component of complement. , 1994, Journal of immunological methods.

[28]  C. Barbas,et al.  Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. von Schaewen,et al.  Molecular characterization of a novel glucose-6-phosphate dehydrogenase from potato (Solanum tuberosum L.). , 2000, The Plant journal : for cell and molecular biology.